Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.09 USD | +3.81% | +1.58% | -15.76% |
Financials (USD)
Sales 2024 * | 274M | Sales 2025 * | 180M | Capitalization | 1.41B |
---|---|---|---|---|---|
Net income 2024 * | -295M | Net income 2025 * | -399M | EV / Sales 2024 * | 2.73 x |
Net cash position 2024 * | 663M | Net cash position 2025 * | 415M | EV / Sales 2025 * | 5.52 x |
P/E ratio 2024 * |
-4.59
x | P/E ratio 2025 * |
-3.5
x | Employees | 577 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.18% |
Latest transcript on Arcus Biosciences, Inc.
1 day | +1.90% | ||
1 week | -0.38% | ||
Current month | +4.71% | ||
1 month | -5.57% | ||
3 months | -16.99% | ||
6 months | -1.38% | ||
Current year | -17.38% |
Managers | Title | Age | Since |
---|---|---|---|
Juan Jaen
FOU | Founder | 66 | 14-12-31 |
Terry Rosen
CEO | Chief Executive Officer | 65 | 14-12-31 |
Robert Goeltz
DFI | Director of Finance/CFO | 51 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry Rosen
CEO | Chief Executive Officer | 65 | 14-12-31 |
Kathryn Falberg
BRD | Director/Board Member | 63 | 17-09-17 |
Yasunori Kaneko
BRD | Director/Board Member | 69 | 15-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.88% | 11 M€ | -6.03% | - | |
0.28% | 26 M€ | -4.59% | - | |
0.12% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 16.09 | +3.81% | 659 494 |
24-06-07 | 15.5 | -2.52% | 514,114 |
24-06-06 | 15.9 | -2.33% | 467,466 |
24-06-05 | 16.28 | +1.75% | 638,775 |
24-06-04 | 16 | +1.01% | 498,235 |
Delayed Quote Nyse, June 10, 2024 at 11:48 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.38% | 1.41B | |
+48.24% | 57.87B | |
+41.65% | 40.25B | |
-7.08% | 39.94B | |
-5.96% | 28.54B | |
+12.09% | 26.4B | |
-20.52% | 19.33B | |
+30.14% | 12.4B | |
-0.74% | 12.23B | |
+24.01% | 12.2B |
- Stock Market
- Equities
- RCUS Stock